Navigation Links
PRT054021 in Medical Technology

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

...ulants, determined that EXPERT met its objectives: prt054021 appeared effective and safe at the two doses studi... look forward to studying the unique properties of prt054021 in additional clinical trials." About prt054021 - Portola's Factor Xa Inhibitor ...

Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

...tled "Evaluation of the Factor Xa (FXA) Inhibitor, prt054021 (PRT021), against Enoxaparin in Randomized Trial f...0 p.m. (CEST) in the exhibition area. About prt054021 -- Portola's Factor Xa Inhibitor prt054021 is an oral Factor Xa inhibitor, an anticoagulant i...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

...replacement (TKR) surgery. Portola expects to move prt054021 into Phase III clinical development in VTE prevent... compare the safety and antithrombotic activity of prt054021 with that of enoxaparin. A steering committee of l... concluded that EXPERT met its objectives and that prt054021 was safe and effective at the doses studied. ...
PRT054021 in other areas

Healthcare Sales & Marketing Network News: Portola Pharmaceuticals ...

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery (HSMN ...

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention ...

Randomized study of PRT054021 40 mg and 15 mg bid vs. enoxaparin 30 mg q12h for ... Drug: PRT054021. Phase II. Study Type: Interventional. Study Design: ...

医药工业研究院_新闻中心

Based on these results, Portola will advance PRT054021 into further clinical testing. ... PRT054021 is an oral Factor Xa inhibitor, an anticoagulant initially being ...

Phase II Study Of Factor Xa Inhibitor Gives Positive Results, Drug ...

... announced positive Phase II data on its lead compound, PRT054021, an oral Factor Xa inhibitor. ... expects to move PRT054021 into Phase III clinical ...

Portola Announces Positive Data on Factor Xa Inhibitor in VTE Trial

Portola Pharmaceuticals has received positive results from EXPERT, a Phase II study of its oral Factor Xa inhibitor, PRT054021, for the prevention of venous ...

Portola Pharmaceuticals, Inc. Announces Positive Phase II EXPERT ...

PRT054021 is an oral Factor Xa inhibitor, an anticoagulant initially being ... In addition, PRT054021 is not excreted in the kidneys and therefore will not ...
Other Tags
(Date:7/4/2015)... , ... July 04, 2015 , ... When a hacker gains access to someone’s email ... at the office. On Wednesday, July 1st, the FTC issued a scam alert about ... of a verification process for a password reset instigated by the hacker. All they ...
(Date:7/3/2015)... (PRWEB) , ... July 03, ... ... announced the sessions and speaker lineup for its 2015 Annual Conference ... place August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, ...
(Date:7/3/2015)... ... 03, 2015 , ... The Erie County Bar Association Institute ... The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... investigating these types of cases. , Each year, New York State residents are ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
(Date:7/2/2015)... ... 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Lone Star State. The premium frozen yogurt chain was listed as #22 on the Inc. ... in the Village at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2
(Date:6/17/2015)... June 17, 2015  Synaptics Inc. (NASDAQ: ... today announced that Xiaomi, one of the world,s ... ClearPad ® family of capacitive touchscreen ... circuits (DDICs) for its latest smartphones, the Xiaomi ... for full in-cell display solutions and DDICs in ...
(Date:6/16/2015)... 2015 Fingerprint Cards (FPC) raises the ... will amount to at least 340 MSEK to that it ... increase in market growth and orders received the revenue guidance ... revenue for 2015 will exceed 1,500 MSEK to an updated ... MSEK. Due to receipt of orders of touch ...
(Date:6/11/2015)... 11, 2015 Daon, a global leader ... its IdentityX Mobile Authentication Platform v4.0 has been ... is an industry consortium launched in 2013 to ... stronger authentication.  In order to receive certification, a ... series of tests that measure compliance and ensure ...
Breaking Biology News(10 mins):Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2
Other Contents